g-PPT, another SCD1 inhibitor, has demonstrated efficacy in reducing the synthesis of polyunsaturated fatty acids, inhibiting triglyceride (TG) synthesis, and preventing lipid droplet accumulation in cancer cells. The gene discussed is SCD; the disease is cancer.